Abstract Diabetic kidney disease (DKD), with the high prevalence of diabetes mellitus, has become the primary cause of end-stage renal disease
These professionals can help determine whether youre truly deficient in these nutrients and advise you on any next steps
Pharmacy Practice in Focus: Health Systems May 2025 Volume 14 Issue 3 APhA 2025: GLP-1 Receptor Agonists vs SGLT2 Inhibitors Show Varied Benefit for Cardiovascular Outcomes in Patients With Diabetes Alana Hippensteele, Lead Editor Key Takeaways GLP-1 receptor agonists excel in stroke prevention, weight loss, and glycemic control, with significant reductions in major adverse cardiovascular events
Accurate Measurement: Use precise laboratory equipment (e.g., insulin syringes for small volumes) to measure both the solvent and the reconstituted solution
L., McGowan, B., Mosenzon, O., Pedersen, S
curcumin, which helps maintain genomic stability and modulates telomere-associated proteins